Leerink Partnrs Cuts Earnings Estimates for Cardinal Health

Cardinal Health, Inc. (NYSE:CAH) – Research analysts at Leerink Partnrs cut their Q3 2025 EPS estimates for shares of Cardinal Health in a note issued to investors on Monday, March 31st. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $2.16 per share for the quarter, down from their previous forecast of $2.18. The consensus estimate for Cardinal Health’s current full-year earnings is $7.95 per share. Leerink Partnrs also issued estimates for Cardinal Health’s FY2027 earnings at $9.90 EPS and FY2028 earnings at $10.84 EPS.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%.

Other analysts also recently issued reports about the company. Mizuho increased their price target on Cardinal Health from $142.00 to $150.00 and gave the company an “outperform” rating in a report on Monday. Wells Fargo & Company increased their target price on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Morgan Stanley boosted their price target on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research report on Friday, January 31st. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Finally, Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average target price of $140.14.

Cardinal Health Trading Up 1.2 %

Shares of CAH stock opened at $138.82 on Thursday. The company has a market cap of $33.53 billion, a PE ratio of 25.90, a P/E/G ratio of 1.49 and a beta of 0.66. The company’s fifty day simple moving average is $128.98 and its 200-day simple moving average is $121.33. Cardinal Health has a 52 week low of $93.17 and a 52 week high of $139.15.

Institutional Investors Weigh In On Cardinal Health

Institutional investors have recently modified their holdings of the stock. Public Sector Pension Investment Board grew its position in shares of Cardinal Health by 12.7% in the 3rd quarter. Public Sector Pension Investment Board now owns 10,637 shares of the company’s stock worth $1,176,000 after acquiring an additional 1,200 shares in the last quarter. Kestra Investment Management LLC bought a new position in Cardinal Health during the third quarter worth $202,000. Paloma Partners Management Co acquired a new position in Cardinal Health in the third quarter worth $283,000. Benjamin Edwards Inc. increased its stake in Cardinal Health by 802.5% during the third quarter. Benjamin Edwards Inc. now owns 4,630 shares of the company’s stock valued at $512,000 after purchasing an additional 4,117 shares during the last quarter. Finally, Centiva Capital LP acquired a new stake in shares of Cardinal Health during the third quarter worth $1,088,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.46%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s payout ratio is currently 37.69%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.